Caroline Tillett - Feb 13, 2025 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role
Chief Scientific Officer
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Stock symbol
KVUE
Transactions as of
Feb 13, 2025
Transactions value $
-$214,059
Form type
4
Date filed
2/18/2025, 06:29 PM
Previous filing
Dec 3, 2024
Next filing
Mar 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KVUE Common Stock Options Exercise $0 +3K +13.96% $0.00 24.5K Feb 13, 2025 Direct F1
transaction KVUE Common Stock Tax liability -$21.5K -1.01K -4.13% $21.23 23.5K Feb 13, 2025 Direct F2
transaction KVUE Common Stock Options Exercise $0 +7.65K +32.56% $0.00 31.1K Feb 14, 2025 Direct F1
transaction KVUE Common Stock Tax liability -$57K -2.62K -8.41% $21.75 28.5K Feb 14, 2025 Direct F2
transaction KVUE Common Stock Options Exercise $0 +19.1K +67.08% $0.00 47.6K Feb 14, 2025 Direct F1
transaction KVUE Common Stock Tax liability -$136K -6.24K -13.09% $21.75 41.4K Feb 14, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVUE Restricted Stock Units Options Exercise $0 -3K -50.05% $0.00 2.99K Feb 13, 2025 Common Stock 3K Direct F1, F3
transaction KVUE Restricted Stock Units Options Exercise $0 -7.65K -100% $0.00 0 Feb 14, 2025 Common Stock 7.65K Direct F1, F4
transaction KVUE Restricted Stock Units Options Exercise $0 -19.1K -100% $0.00 0 Feb 14, 2025 Common Stock 19.1K Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Share Units (RSUs) converted into shares of Common Stock on a one-for-one basis upon vesting.
F2 Shares withheld for payment of taxes upon vesting of RSUs.
F3 This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date.
F4 This award vested in full on 02/14/2025.
F5 These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level.